Cyclooxygenase (COX)-2 influences cardiovascular disease and serum concentration of high-sensitivity C-reactive protein (hsCRP). The study purpose was to determine the influence of single nucleotide polymorphisms (SNPs) of the COX-2 gene on abdominal aortic aneurysm (AAA) development and serum hsCRP concentrations.
Patients and Methods
Patients with AAA and disease-free controls were recruited. High-sensitivity C-reactive protein was measured by an enzyme-linked immunosorbent assay (ELISA) test. The distributions of COX-2 SNPs were investigated (rs20417 and rs4648307). The influence of the COX-2 SNPs on the hsCRP serum concentration was assessed.
Results
A total of 230 patients with AAA and 279 controls were included. No difference was found in the genotype distribution of the COX-2 SNPs rs20417 (P = .26) and rs4648307 (P = .90). They did not influence the hsCRP concentration (P = .24 and P = .61, respectively). Haplotype analysis of COX-2 SNPs revealed no difference.
Conclusion
These COX-2 SNPs do not play any role in AAA development and do not influence serum hsCRP. These results differentiate AAA development from atherosclerotic diseases.
O'NeillG.P., Ford-HutchinsonA.W.Expression of mRNA for cyclooxygenase- I and cyclooxygenase-2 in human tissues.FEBS Lett.1993; 330(2): 156–160.
11.
ApplebyS.B., RistimakiA., NeilsonK., NarkoK., HlaT.Structure of the human cyclooxygenase-2 gene.Biochem J.1994; 302(pt 3): 723–727.
12.
ChenG., WoodE.G., WangS.H., WarnerT.D.Expression of cyclooxygenase-2 in rat vascular smooth muscle cells is unrelated to nuclear factor-kappaB activation.Life Sci.1999; 64(14): 1231–1242.
13.
CipolloneF., PronteraC., PiniB.Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability.Circulation.2001; 104(8): 921–927.
14.
CipolloneF., RoccaB., PatronoC.Cyclooxygenase expression and inhibition in atherothrombosis.Arterioscler Thromb Vasc Biol.2004; 24(2): 246–255.
15.
SeibertK., ZhangY., LeahyK.Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain.Proc Natl Acad Sci U S A.1994; 91(25): 12013–12017.
16.
ParenteL., PerrettiM.Advances in the pathophysiology of constitutive and inducible cyclooxygenases: two enzymes in the spotlight.Biochem Pharmacol.2003; 65(2): 153–159.
17.
KosakaT., MiyataA., IharaH.Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2.Eur J Biochem.1994; 221(3): 889–897.
18.
CipolloneF., ToniatoE., MartinottiS. for the Identification of New Elements of Plaque Stability (INES) Study Group. A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke.JAMA.2004; 291(18): 2221–2228.
XuQ., JiY.S., SmedtjeJ.F.JrSpI increases expression of cyclooxygenase-2 in hypoxic vascular endothelium: implications for the mechanisms of aortic aneurysm and heart failure.J Biol Chem.2000; 275(32): 24583–24589.
21.
CullenL., KellyL., ConnorS.O., FitzgeraldD.J.Selective cyclooxygenase-2 inhibition by nimesulide in man.J Pharmacol Exp Ther.1998; 287(2): 578–582.
McAdamB.F., Catella-LawsonF., MardiniI.A., KapoorS., LawsonJ.A., FitzGeraldG.A.Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2.Proc Natl Acad Sci U S A.1999; 96(1): 272–277.
24.
MelroseJ., WhitelockJ., XuQ., GhoshP.Pathogenesis of abdominal aortic aneurysms: a possible role of differential production of proteoglycans by smooth muscle cells.J Vasc Surg.1998; 28(4): 676–686.
25.
JuvonenJ., SurcelH.M., SattaJ.Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm.Arterioscler Thromb Vasc Biol.1997; 17(11): 2843–2847.
26.
NewmanK.M., Jean-ClaudeJ., LiH., RameyW.G., TilsonM.D.Cytokines that activate proteolysis are increased in abdominal aortic aneurysms.Circulation.1994; 90(5 pt 2): II224–II227.
27.
KochA.E., KunkelS.L., PearceW.H.Enhanced production of the chemotactic cytokines interleukin-8 and moncyte chemoattractant protein-1 in human abdominal aortic aneurysms.Am J Pathol.1993; 142(5): 1423–1431.
28.
HerronG.S., UnemoriE., WongM., RappJ.H., HibbsM.H., StoneyR.J.Connective tissue proteinases and inhibitors in abdominal aortic aneurysms. Involvement of the vasa vasorum in the pathogenesis of aortic aneurysms.Arterioscler Thomb.1991; 11(6): 1667–1677.
29.
BadgerS.A., SoongC.V., O'DonnellM.E., MercerC., YoungI.S., HughesA.E.C-reactive protein (CRP) elevation in patients with abdominal aortic aneurysm is independent of the most important CRP genetic polymorphism.J Vasc Surg.2009; 49(1): 178–184.
30.
HegenerH.H., DiehlK.A., KurthT., GazianoJ.M., RidkerP.M., ZeeR.Y.L.Polymorphisms of prostaglandin-endoperoxide synthase 2 gene, and prostaglandin-E receptor 2 gene, C-reactive protein concentrations and risk of atherosclerosis: a nested case-control approach.J Thromb Haemost.2006; 4(8): 1718–1722.
31.
KohsakaS., VolcikK.A., FolsomA.R.Increased risk of incident stroke associated with the cyclooxygenase 2 (COX-2) G-765C polymorphism in African-Americans: the Atherosclerosis Risk in Communities Study.Atherosclerosis.2008; 196(2): 926–930.
32.
HuuskonenK.H., KunnasT.A., TannerM.M.COX-2 gene promoter polymorphism and coronary artery disease in middle-aged men: the Helsinki sudden death study.Mediators Inflamm.2008; 2008: 289453.
